Waters Corporation (WAT) Shares Bought by Zions Bancorporation
Zions Bancorporation lifted its holdings in shares of Waters Corporation (NYSE:WAT) by 12,075.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,461 shares of the medical instruments supplier’s stock after purchasing an additional 1,449 shares during the quarter. Zions Bancorporation’s holdings in Waters were worth $262,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Capital International Investors grew its holdings in shares of Waters by 1.8% during the 3rd quarter. Capital International Investors now owns 341,010 shares of the medical instruments supplier’s stock worth $61,218,000 after purchasing an additional 6,192 shares during the period. Janus Henderson Group PLC grew its holdings in shares of Waters by 1.6% during the 3rd quarter. Janus Henderson Group PLC now owns 1,959,850 shares of the medical instruments supplier’s stock worth $351,832,000 after purchasing an additional 30,057 shares during the period. Vident Investment Advisory LLC purchased a new position in shares of Waters during the 3rd quarter worth $429,000. Chevy Chase Trust Holdings Inc. grew its holdings in shares of Waters by 1.0% during the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 69,620 shares of the medical instruments supplier’s stock worth $12,498,000 after purchasing an additional 667 shares during the period. Finally, Magnetar Financial LLC purchased a new position in shares of Waters during the 3rd quarter worth $720,000. Institutional investors and hedge funds own 92.29% of the company’s stock.
Waters Corporation (NYSE:WAT) traded down $1.53 during mid-day trading on Tuesday, reaching $197.76. The company’s stock had a trading volume of 595,000 shares, compared to its average volume of 514,066. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. The firm has a market cap of $15,850.13, a price-to-earnings ratio of 27.68, a P/E/G ratio of 2.89 and a beta of 0.82. Waters Corporation has a 52 week low of $133.71 and a 52 week high of $201.95.
Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.03. The company had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. Waters had a return on equity of 23.61% and a net margin of 24.34%. Waters’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.57 EPS. equities analysts anticipate that Waters Corporation will post 7.42 earnings per share for the current fiscal year.
A number of equities analysts recently commented on WAT shares. Zacks Investment Research upgraded Waters from a “hold” rating to a “buy” rating and set a $211.00 target price for the company in a report on Monday, October 23rd. Barclays raised their target price on Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a report on Wednesday, October 25th. Morgan Stanley upgraded Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 target price for the company in a report on Monday, December 4th. Deutsche Bank raised their target price on Waters from $199.00 to $200.00 and gave the company a “hold” rating in a report on Wednesday, October 25th. Finally, Cowen restated a “hold” rating and set a $190.00 target price on shares of Waters in a report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Waters has a consensus rating of “Hold” and a consensus price target of $193.62.
In other Waters news, SVP Elizabeth B. Rae sold 12,000 shares of the stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $197.95, for a total value of $2,375,400.00. Following the sale, the senior vice president now owns 18,129 shares of the company’s stock, valued at approximately $3,588,635.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William J. Miller sold 3,500 shares of the stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $194.94, for a total value of $682,290.00. Following the completion of the sale, the director now directly owns 25,849 shares in the company, valued at approximately $5,039,004.06. The disclosure for this sale can be found here. Insiders sold a total of 45,913 shares of company stock worth $9,084,685 in the last ninety days. 5.07% of the stock is owned by corporate insiders.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with Analyst Ratings Network's FREE daily email newsletter.